BBVA Issues $1 Billion in Convertible Preferred Shares to Strengthen Capital
Discover outperforming stocks and invest smarter with Top Smart Score StocksFilter, analyze, and streamline your ...
Bemax Inc. Announces Special Dividend of Bemax Convertible Preferred Stock
Regarding the dividend, Taiwo Aimasiko, Bemax CEO, commented, "Today we are rewarding our passionate and supportive shareholders with a dividend of Bemax Series A Convertible Preferred Stock. Each ...
Hosted on MSN5d
How to Calculate the Value of Preferred Stock
Preferred stock combines features of both equity and debt. Unlike common stock, preferred shares often offer fixed dividends ...
Nasdaq8d
EPR Properties's 9.00% Series E Cumulative Convertible Preferred Shares Goes Ex-Dividend Soon
On 12/31/24, EPR Properties's 9.00% Series E Cumulative Convertible Preferred Shares (Symbol: EPR.PRE) will trade ex-dividend, for its quarterly dividend of $0.5625, payable on 1/15/25.
Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell ...
ETF Daily News12d
Coretec Group Enters Into Subscription Agreement for Series D Convertible Preferred Shares
These Series D Preferred Shares, each with a stated value of $100 per share, are convertible into common stock at a fixed conversion price of $0.015 per Conversion Share. Additionally, in a unique ...
Loop Industries Closes Transactions with Reed Management SAS, Secures EUR 20 Million in Preferred Stock Financing and Licensing Deal
Loop Industries, Inc. recently concluded a series of significant transactions with Reed Management SAS, as disclosed in a ...
TMCnet5d
HNO International Announces an 82% Reduction in Outstanding Shares of Common Stock as 360 Million Shares Have Been Exchanged
After the return exchange of 360 million shares of Common Stock owned by Donald Owens, Chairman of the Board of Directors and ...
Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
David Lazar agrees to invest $3.1 million in Preferred Stock and becomes Interim CEOBERKELEY HEIGHTS, N.J., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: ...